Your browser doesn't support javascript.
loading
Evidence-based strategies for the characterisation of human drug and chemical glucuronidation in vitro and UDP-glucuronosyltransferase reaction phenotyping.
Miners, John O; Rowland, Andrew; Novak, Jonathan J; Lapham, Kimberly; Goosen, Theunis C.
Affiliation
  • Miners JO; Department of Clinical Pharmacology and Flinders Centre for Innovation in Cancer, College of Medicine and Public Health, Flinders University, Adelaide, Australia. Electronic address: john.miners@flinders.edu.au.
  • Rowland A; Department of Clinical Pharmacology and Flinders Centre for Innovation in Cancer, College of Medicine and Public Health, Flinders University, Adelaide, Australia.
  • Novak JJ; Medicine Design Pfizer Inc, Groton, CT, USA.
  • Lapham K; Medicine Design Pfizer Inc, Groton, CT, USA.
  • Goosen TC; Medicine Design Pfizer Inc, Groton, CT, USA.
Pharmacol Ther ; 218: 107689, 2021 02.
Article in En | MEDLINE | ID: mdl-32980440
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glucuronosyltransferase / Glucuronides Type of study: Guideline Limits: Humans Language: En Journal: Pharmacol Ther Year: 2021 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glucuronosyltransferase / Glucuronides Type of study: Guideline Limits: Humans Language: En Journal: Pharmacol Ther Year: 2021 Document type: Article